Malignant neoplasm of lung
|
0.340 |
Biomarker
|
disease |
BEFREE |
MiR-410 affects the proliferation and apoptosis of lung cancer A549 cells through regulation of SOCS3/JAK-STAT signaling pathway.
|
30280782 |
2018 |
Malignant neoplasm of lung
|
0.340 |
Biomarker
|
disease |
BEFREE |
MiR-410 affects the proliferation and apoptosis of lung cancer A549 cells through regulation of SOCS3/JAK-STAT signaling pathway.
|
30280781 |
2018 |
Malignant neoplasm of lung
|
0.340 |
Biomarker
|
disease |
BEFREE |
MiR-410 induces stemness by inhibiting Gsk3β but upregulating β-catenin in non-small cells lung cancer.
|
28076327 |
2017 |
Malignant neoplasm of lung
|
0.340 |
Biomarker
|
disease |
BEFREE |
Our data provided new knowledge regarding the role of miR-410 in the lung cancer progression.
|
26149213 |
2015 |
Malignant neoplasm of lung
|
0.340 |
Biomarker
|
disease |
CTD_human |
Clinical biomarkers of pulmonary carcinoid tumors in never smokers via profiling miRNA and target mRNA.
|
25105010 |
2014 |
Papillary thyroid carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer.
|
28030816 |
2017 |
Nonmedullary Thyroid Carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer.
|
28030816 |
2017 |
Familial Nonmedullary Thyroid Cancer
|
0.300 |
Biomarker
|
disease |
CTD_human |
Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer.
|
28030816 |
2017 |
Carcinoid Tumor
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Clinical biomarkers of pulmonary carcinoid tumors in never smokers via profiling miRNA and target mRNA.
|
25105010 |
2014 |
Lung Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Clinical biomarkers of pulmonary carcinoid tumors in never smokers via profiling miRNA and target mRNA.
|
25105010 |
2014 |
Carcinoid, Goblet Cell
|
0.300 |
Biomarker
|
disease |
CTD_human |
Clinical biomarkers of pulmonary carcinoid tumors in never smokers via profiling miRNA and target mRNA.
|
25105010 |
2014 |
Argentaffinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Clinical biomarkers of pulmonary carcinoid tumors in never smokers via profiling miRNA and target mRNA.
|
25105010 |
2014 |
Fatty Liver
|
0.300 |
Biomarker
|
disease |
CTD_human |
Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis.
|
22363424 |
2012 |
Hepatitis, Toxic
|
0.300 |
Biomarker
|
disease |
CTD_human |
Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis.
|
22363424 |
2012 |
Drug-Induced Liver Disease
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis.
|
22363424 |
2012 |
Hepatitis, Drug-Induced
|
0.300 |
Biomarker
|
disease |
CTD_human |
Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis.
|
22363424 |
2012 |
Steatohepatitis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis.
|
22363424 |
2012 |
Drug-Induced Acute Liver Injury
|
0.300 |
Biomarker
|
disease |
CTD_human |
Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis.
|
22363424 |
2012 |
Chemical and Drug Induced Liver Injury
|
0.300 |
Biomarker
|
disease |
CTD_human |
Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis.
|
22363424 |
2012 |
Chemically-Induced Liver Toxicity
|
0.300 |
Biomarker
|
disease |
CTD_human |
Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis.
|
22363424 |
2012 |
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
miR-410-3p acts as an oncogene or a tumor suppressor in some malignancies.
|
30242542 |
2019 |
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The current study indicated that miR-410 negatively regulates the expression of DKK-1 <i>in vitro</i>. miR-410 promotes malignancy phenotypes in CRC cell lines.
|
30655833 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
miR-410-3p acts as an oncogene or a tumor suppressor in some malignancies.
|
30242542 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Therefore, miR-410-3p may serve as a novel tumor suppressor gene in RMS, and could possess diagnostic and therapeutic potentials for the treatment of RMS.
|
31289572 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
miR-410-3p acts as an oncomiR in gonadotroph and corticotroph adenoma cells, while as a tumor suppressor miR in somatotroph adenoma cells.
|
31165412 |
2019 |